Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease

Journal of Neurology, Neurosurgery, and Psychiatry
Liesl M AllcockDavid J Burn

Abstract

The frequency of orthostatic hypotension (OH) in cohorts of patients recruited through hospital Parkinson's disease (PD) clinics ranges from 16% to 58%. However, hospital based cohorts may be subject to ascertainment bias. The aim of this study was to determine the frequency of OH in a community based population of PD patients and to determine the demographic features of patients with and without OH. Forty two (47%) of patients met the criteria for OH. Subjects with OH were older than those without OH, but there was no difference in PD disease duration or severity, MMSE or depression rating between the groups.

Citations

Sep 20, 2008·Journal of Neurology·Guido AlvesJan Petter Larsen
Nov 28, 2012·Journal of Neurology·Manuela MetzlerGregor K Wenning
Feb 16, 2006·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·David S Goldstein
Mar 29, 2007·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Juan IdiaquezLily Ríos
Apr 23, 2008·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Phillip A Low
Feb 10, 2009·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Chie-Wei FanConal J Cunningham
Jul 9, 2013·Current Hypertension Reports·Amy C Arnold, Cyndya Shibao
Mar 29, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·V PursiainenV V Myllylä
Jan 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Barone
Apr 3, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·Nick MillerDavid J Burn
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Steven Wishart, Graeme J A Macphee
Apr 15, 2014·Vascular Health and Risk Management·Stuart H Isaacson, Julia Skettini
Mar 19, 2014·Parkinson's Disease·Seyed-Mohammad Fereshtehnejad, Johan Lökk
Mar 5, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Luisa SambatiPietro Cortelli
May 1, 2011·Journal of Movement Disorders·Hyo-Jin BaeJae Woo Kim
Sep 10, 2010·Neurologia i neurochirurgia polska·Hanna CzarkowskaAndrzej Szczudlik
May 15, 2013·Archivos de cardiología de México·Mayela Rodríguez-ViolanteTeresa Corona
Mar 27, 2012·La Presse médicale·Jean-Jacques MonsuezSid Belbachir
Oct 18, 2011·Journal of the Neurological Sciences·Maria G Cersosimo, Eduardo E Benarroch
May 17, 2011·Parkinsonism & Related Disorders·Daan C VelseboerRob M A de Bie
Feb 25, 2009·Revista española de geriatría y gerontología·Christian Villavicencio-ChávezAntón M Cervera
Mar 5, 2008·Parkinsonism & Related Disorders·Giuseppe MecoMarcella Valente
Dec 8, 2007·Parkinsonism & Related Disorders·Colin Powell
Jul 28, 2007·Disease-a-month : DM·Jordan S Dubow
Sep 22, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Turi O DalakerRobert Zivadinov
Jan 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Maarit MatinolliVilho V Myllylä
Mar 11, 2009·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Ingrid Pretzer-AboffBarbara Resnick
Sep 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Liesl M AllcockDavid J Burn
Jan 19, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Francesca Del SorboAlberto Albanese
May 7, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Anne Pavy-Le TraonOlivier Rascol
Mar 12, 2010·Journal of Clinical Pharmacology·David S GoldsteinIrwin J Kopin
Dec 12, 2012·Journal of Internal Medicine·A Fedorowski, O Melander
Dec 10, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Robert A HauserGerry Rowse
Nov 3, 2007·The American Journal of Medicine·Cyndya ShibaoMarie R Griffin
Sep 27, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Emma J BurtonJohn T O'Brien
Sep 12, 2006·Parkinsonism & Related Disorders·Spiridon Papapetropoulos, Deborah C Mash
Apr 20, 2006·Parkinsonism & Related Disorders·Emilia MartignoniGiuseppe Nappi
Jul 15, 2015·Parkinson's Disease·Carlos Henrique Ferreira CamargoEdmar Miyoshi
Jul 19, 2011·Journal of the Neurological Sciences·Yehonatan Sharabi, David S Goldstein
Aug 19, 2011·Journal of the Neurological Sciences·Valeria IodiceChristopher J Mathias
May 20, 2008·Parkinsonism & Related Disorders·L M AllcockD J Burn
Sep 4, 2010·American Journal of Hypertension·Luke J Benvenuto, Lawrence R Krakoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
J M SenardJ L Montastruc
Archives of Neurology
Ubaldo BonuccelliAlberto Piaggesi
Movement Disorders : Official Journal of the Movement Disorder Society
Jenny Jamnadas-KhodaSubbakrishna K Dodaballapur
© 2021 Meta ULC. All rights reserved